stockrow
Monday 9 November 2026
Export VRXA’s income statement to Excel — free account
Veraxa Biotech AG
VRXA
0.95
0.00
0.00%
Follow VRXA
Alert me
Veraxa Biotech AG (VRXA) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NGEN NervGen Pharma Corp. compare | n/m |
| MGNX MacroGenics, Inc. compare | n/m |
| ANTX AN2 Therapeutics, Inc. compare | n/m |
| SION Sionna Therapeutics, Inc. compare | n/m |
| CUE Cue Biopharma, Inc. compare | n/m |
| MSLE Satellos Bioscience Inc. compare | n/m |
| INO Inovio Pharmaceuticals, Inc. compare | n/m |
| ADAG Adagene Inc. Sponsored ADR compare | — |
| VRXA Veraxa Biotech AG | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)